Cytiva completes projects in Asia, US & Europe with $1.6 B strategic investment

June 13, 2025 | Friday | News

Most major projects completed in Europe and Asia-Pacific, US resins site slated to be up and running in 2028

Cytiva, a Danaher company and global life sciences leader, has completed significant expansion projects in several locations in the United States, Europe, and Asia as part of its ongoing commitment to enhancing delivery for customers developing and manufacturing advanced therapeutics. Set to continue through 2028, these expansions will meet increased customer demand as part of Cytiva’s long-term growth plan and in-region manufacturing strategy, supported by an investment of $1.6 billion since 2019.

The latest investments in chromatography resins and filtration include:

The start of filtration manufacturing at Cytiva’s Innovation Hub and manufacturing facility in South Korea in 2026 to address increased demand for high-quality filtration solutions in Asia-Pacific.

Approximately double production capacity of chromatography resins manufacturing in Uppsala, Sweden with the addition of new factories, new equipment, as well as improved automation capabilities and a new tank farm for solvent storage.

Enhanced local supply in North America with the construction of a second resins manufacturing site with approximately 100 full-time associates in Muskegon, Michigan, now. The site is slated to be fully operational with plans to hire about 100 more associates by end of 2028.

New filtration manufacturing lines in Pensacola, Florida which will increase the site’s production capacity for filter membranes for North America by 20% by August 2025, with its most-ordered products stocked on-the-shelf.

Cytiva’s latest capacity investments are also expanding “in-region, for region” manufacturing of single-use bags, which enable customers to quickly and efficiently work with and change batches during their processes. Specific developments include the trebling of single-use consumable manufacturing capacity in Beijing, China, doubling of manufacturing capacity in Duncan, South Carolina, and sustained manufacturing capacity in Medemblik, Netherlands.

Cytiva is increasing access to cell culture media in North America by expanding dry powder and liquid media manufacturing capacity in Logan, Utah, for large volumes and adding high-speed bottle filling for small volumes. 

Sign up for the editor pick and get articles like this delivered right to your inbox.

+Country Code-Phone Number(xxx-xxxxxxx)

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account